RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,306 | +39.5% | 10,395 | +0.3% | 0.00% | – |
| Q2 2023 | $170,854 | +10.2% | 10,361 | -23.1% | 0.00% | – |
| Q1 2022 | $155,000 | -7.7% | 13,465 | -19.4% | 0.00% | – |
| Q4 2021 | $168,000 | -21.5% | 16,707 | +2.0% | 0.00% | -100.0% |
| Q3 2021 | $214,000 | -46.5% | 16,375 | -19.9% | 0.00% | 0.0% |
| Q2 2021 | $400,000 | +10.5% | 20,450 | +20.3% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -14.6% | 16,996 | +19.1% | 0.00% | -50.0% |
| Q4 2020 | $424,000 | +74.5% | 14,269 | +27.1% | 0.00% | +100.0% |
| Q3 2020 | $243,000 | -6.2% | 11,229 | -3.3% | 0.00% | 0.0% |
| Q2 2020 | $259,000 | -16.2% | 11,612 | -13.8% | 0.00% | 0.0% |
| Q4 2019 | $309,000 | +19.8% | 13,472 | +12.7% | 0.00% | 0.0% |
| Q3 2019 | $258,000 | +0.4% | 11,958 | +2.5% | 0.00% | -50.0% |
| Q2 2019 | $257,000 | -29.8% | 11,661 | -12.6% | 0.00% | 0.0% |
| Q1 2019 | $366,000 | +2.5% | 13,343 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $357,000 | – | 13,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $9,074,000 | 1.96% |
| NEA Management Company, LLC | 4,912,306 | $49,025,000 | 0.99% |
| RA Capital Management | 4,871,067 | $48,613,000 | 0.86% |
| Samsara BioCapital, LLC | 345,293 | $3,446,000 | 0.67% |
| Endurant Capital Management LP | 197,462 | $1,971,000 | 0.48% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,867,467 | $18,637,000 | 0.39% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $274,000 | 0.20% |
| Baker Brothers Advisors | 3,863,239 | $38,555,000 | 0.19% |
| Rock Springs Capital Management LP | 627,180 | $6,259,000 | 0.14% |
| Aquatic Capital Management LLC | 4,000 | $40,000 | 0.08% |